Want to see CCEL full AI Analyst Report?

Cryo-Cell International (CCEL) Price & Analysis

54 Followers

CCEL Stock Chart & Stats

$4.09

-$0.37(-4.74%)

At close: Jan 08 4:00 PM EST

$4.09

-$0.37(-4.74%)

Day’s Range― - ―

52-Week Range$2.72 - $5.43

Previous CloseN/A

Volume3.40K

Average Volume (3M)4.07K

Market Cap

$25.70M

Enterprise Value$30.58M

Total Cash (Recent Filing)$2.90M

Total Debt (Recent Filing)$2.40M

Price to Earnings (P/E)―

Beta0.14

Next Earnings

Jul 09, 2026

EPS Estimate

Next Dividend Ex-DateN/A

Dividend Yield11.14%

Share Statistics

EPS (TTM)-0.32

Shares Outstanding8,055,150

10 Day Avg. Volume4,683

30 Day Avg. Volume4,066

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)-1.73

Price to Sales (P/S)1.02

P/FCF Ratio6.12

Enterprise Value/Market Cap1.19

Enterprise Value/Revenue0.98

Enterprise Value/Gross Profit1.26

Enterprise Value/Ebitda51.87

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusHold

Number of Analyst Covering1

EPS Forecast (FY)0.11

Revenue Forecast (FY)$30.30M

Bulls Say, Bears Say

Bulls Say

Strong Gross MarginsMid-70% gross margins point to durable unit economics for cryogenic storage: low incremental costs on recurring storage fees and upfront processing. This margin buffer supports service quality, reinvestment and margin resilience even if revenue growth is uneven over months.

Consistent Operating Cash GenerationPositive operating cash flow across periods indicates the core biobanking model (upfront fees + recurring storage) converts to cash even amid accounting losses. This cash generation provides a durable funding source for operations and remediation actions, lowering short-term reliance on external capital.

Regulatory Runway To Remediate Listing IssuesAcceptance of a remediation plan by the exchange grants multi-quarter runway to address balance-sheet deficits and operational weaknesses. Preserving listing status maintains market visibility and gives management time to implement structural fixes, reducing immediate delisting risk.

Bears Say

Persistent Negative EquityNegative stockholders' equity materially weakens financial flexibility and creditor/investor confidence. It constrains borrowing capacity, increases the likelihood of dilutive capital raises or covenant pressure, and is a structural balance-sheet overhang that impairs long-term strategic options.

Revenue Decline And Recurring LossesA weakening top line combined with persistent net losses reduces operating leverage and the ability to invest in growth or margin-improving initiatives. Over several quarters this undermines scale economics for marketing and retention, making durable recovery harder without structural changes.

Volatile Free Cash FlowHistoric FCF volatility and sharply negative TTM FCF growth increase liquidity and planning risks. Even with recent positive OCF, unpredictable cash generation complicates sustained debt reduction, capital spending, and execution of remediation steps, especially given negative equity.

Cryo-Cell International News

Cryo-Cell says NYSE American accepts compliance plan

Cryo-Cell (CCEL) announced that the NYSE American has accepted the company’s previously submitted plan to regain compliance with...

2M ago

CCEL

Cryo-Cell Plan Accepted to Regain NYSE Compliance

Cryo-Cell International ( ($CCEL) ) has issued an update. On May 6, 2026, Cryo-Cell International received notice that...

2M ago

CCEL

Cryo-Cell International Faces NYSE American Compliance Review and Potential Delisting Risk Ahead of 2027 Deadline

Cryo-Cell International (CCEL) has disclosed a new risk, in the Regulation category. Cryo-Cell International faces uncertainty as NYSE...

3M ago

CCEL

Cryo-Cell reports Q1 EPS 1c vs. 3c last year

Reports Q1 revenue $7.68M vs. $7.97M last year. The company said, “The revenues for the first quarter of...

3M ago

CCEL

Cryo-Cell Faces NYSE American Listing Compliance Challenges

The latest announcement is out from Cryo-Cell International ( ($CCEL) ). On March 9, 2026, Cryo-Cell International, Inc....

4M ago

CCEL

Cryo-Cell International Halts Q4 2025 Dividend Declaration

Cryo-Cell International ( ($CCEL) ) has shared an update. Cryo-Cell International announced that it will not declare a...

8M ago

CCEL

Cryo-Cell International Amends Credit Agreement with Susser Bank

Cryo-Cell International ( ($CCEL) ) has shared an update. Cryo-Cell International, Inc. announced a Fifth Amendment to its...

8M ago

CCEL

Cryo-Cell downgraded to Hold from Buy at Maxim

Maxim analyst Allen Klee downgraded Cryo-Cell (CCEL) to Hold from Buy. Published first on TheFly – the ultimate...

8M ago

CCEL

Cryo-Cell Schedules 2025 Annual Stockholders Meeting

Cryo-Cell International ( ($CCEL) ) has provided an announcement. Cryo-Cell International has scheduled its 2025 Annual Meeting of...

10M ago

CCEL

Cryo-Cell will not declare dividend in Q3

Cryo-Cell (CCEL) announced that the company will not declare a quarterly cash dividend for the third quarter of...

11M ago

CCEL

Cryo-Cell reports Q2 EPS 4c vs. 8c last year.

Reports Q2 revenue $7.9M vs. $8.0M last year. Published first on TheFly – the ultimate source for real-time,...

12M ago

CCEL

Cryo-Cell Faces License Termination by Duke University

Cryo-Cell International ( ($CCEL) ) has issued an update. Cryo-Cell International, Inc. has received a notice of termination...

1y ago

CCEL

Cryo-Cell International Declares Reduced Quarterly Dividend

An announcement from Cryo-Cell International ( ($CCEL) ) is now available. On May 7, 2025, Cryo-Cell International‘s Board...

1y ago

CCEL

Cryo-Cell International: Strong Financial Performance and Strategic Positioning with Potential Upside

In a report released yesterday, Allen Klee from Maxim Group reiterated a Buy rating on Cryo-Cell International (CCEL...

1y ago

CCEL

CCEL FAQ

What was Cryo-Cell International Inc’s price range in the past 12 months?

Cryo-Cell International Inc lowest stock price was $2.72 and its highest was $5.43 in the past 12 months.

What is Cryo-Cell International Inc’s market cap?

Cryo-Cell International Inc’s market cap is $25.70M.

When is Cryo-Cell International Inc’s upcoming earnings report date?

Cryo-Cell International Inc’s upcoming earnings report date is Jul 09, 2026 which is in 8 days.

How were Cryo-Cell International Inc’s earnings last quarter?

Cryo-Cell International Inc released its earnings results on Apr 14, 2026. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.02 by $0.03.

Is Cryo-Cell International Inc overvalued?

According to Wall Street analysts Cryo-Cell International Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cryo-Cell International Inc pay dividends?

Cryo-Cell International Inc pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 11.14%. See more information on Cryo-Cell International Inc dividends here

What is Cryo-Cell International Inc’s EPS estimate?

Cryo-Cell International Inc’s EPS estimate is 0.

How many shares outstanding does Cryo-Cell International Inc have?

Cryo-Cell International Inc has 8,055,150 shares outstanding.

What happened to Cryo-Cell International Inc’s price movement after its last earnings report?

Cryo-Cell International Inc reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.02. Following the earnings report the stock price went up 1.09%.

Which hedge fund is a major shareholder of Cryo-Cell International Inc?

Currently, no hedge funds are holding shares in CCEL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cryo-Cell International Inc

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Cryo-Cell International (CCEL) Earnings & Revenues

Historic Earnings Reports

CCEL Stock 12 Month Forecast

Average Price Target

―

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","-1":"-$1","0.75":"$0.75","2.5":"$2.5","4.25":"$4.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">―</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.75,2.5,4.25,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.19,2.9446153846153846,2.6992307692307693,2.453846153846154,2.2084615384615383,1.9630769230769232,1.7176923076923076,1.4723076923076923,1.226923076923077,0.9815384615384617,0.7361538461538464,0.49076923076923107,0.2453846153846153,{"y":null,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.19,2.9446153846153846,2.6992307692307693,2.453846153846154,2.2084615384615383,1.9630769230769232,1.7176923076923076,1.4723076923076923,1.226923076923077,0.9815384615384617,0.7361538461538464,0.49076923076923107,0.2453846153846153,{"y":null,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.19,2.9446153846153846,2.6992307692307693,2.453846153846154,2.2084615384615383,1.9630769230769232,1.7176923076923076,1.4723076923076923,1.226923076923077,0.9815384615384617,0.7361538461538464,0.49076923076923107,0.2453846153846153,{"y":null,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.07,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.96,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.72,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.6,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.51,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.98,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.439,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.38,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.28,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.61,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.5,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.55,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.19,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >